Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Looking for ways to get cash fast when unemployed? Act now to discover the best opportunities for immediate income!
20,927 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As market volatility lingers in 2026, the timing of Social Security claims tied to birthdays can dramatically alter m...
July markets showed a cautious tone as Ondas revealed a fresh $70 million order backlog. The stock jumped, while majo...
Tariffs announced by the administration sparked immediate market volatility and raised red flags for investors. This ...
Insider moves can tell us a lot about a stock’s near-term path. When Intuitive Machines’ CEO disclosed a $1.39 millio...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
TeraWulf releases Q4 2025 results after the bell, signaling a shift from Bitcoin mining to AI compute. After-hours tr...
Tariff refund delays could threaten cash flow for thousands of importers, with a Cato Institute estimate placing the ...
Markets tremble as Iran’s leadership shift and rising oil force volatility. A JPMorgan strategist cautions against qu...
Solmate plans a reverse stock split to fund a Solana-focused hub in the UAE, part of a broader pivot that includes ex...
The 2026 Social Security COLA is 2.8%, but higher-income retirees face loss due to Medicare IRMAA surcharges that swa...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...